Precision editing of the gut microbiota ameliorates colitis

Area of Science:

• Microbiology
• Gastroenterology
• Pharmacology

Background:

• Inflammatory gastrointestinal diseases are linked to gut dysbiosis, marked by an increase in facultative anaerobic bacteria like Enterobacteriaceae (Proteobacteria).
• This dysbiosis involves specific microbial respiratory pathways dependent on molybdenum-cofactor, which are active during inflammation.

Purpose of the Study:

• To investigate if tungstate treatment can prevent dysbiotic expansion of Enterobacteriaceae during gut inflammation.
• To evaluate the impact of tungstate on microbial communities under both inflammatory and homeostatic conditions.
• To assess the therapeutic potential of tungstate-mediated microbiota editing in reducing intestinal inflammation.

Main Methods:

• Treatment with tungstate was administered to mouse models of colitis.
• Microbiota composition was analyzed under inflammatory and homeostatic conditions.
• The effect of tungstate on molybdenum-cofactor-dependent microbial respiratory pathways was examined.

Main Results:

• Tungstate treatment effectively prevented the dysbiotic expansion of Enterobacteriaceae during gut inflammation.
• Tungstate selectively inhibited inflammatory-specific microbial respiratory pathways.
• Tungstate caused minimal alterations to the microbiota composition under homeostatic conditions.
• Microbiota editing via tungstate significantly reduced the severity of intestinal inflammation in colitis models.

Conclusions:

• Tungstate acts as a precision editing tool for the gut microbiota during inflammation.
• Targeting molybdenum-cofactor-dependent pathways with tungstate ameliorates dysbiosis-associated inflammation.
• This approach offers a potential therapeutic strategy for inflammatory gut diseases.